본문 바로가기
KERD
논문KCI 등재

Vortioxetine Induced Hypomania: A Case Presentation and Review of the Literature

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

Antidepressant-induced hypomania/mania is a complex issue that can be seen in mood disorders but is not clarified. There are case reports in the literature regarding vortioxetine-induced mania and hypomania; however, there is insufficient data. Here, we aim to present a case of vortioxetine-induced hypomania in a major depressive disorder patient who previously used various antidepressants but did not experience hypomania or mania. Our case is expected to contribute to the literature.

Abstract

Antidepressant-induced hypomania/mania is a complex issue that can be seen in mood disorders but is not clarified. There are case reports in the literature regarding vortioxetine-induced mania and hypomania; however, there is insufficient data. Here, we aim to present a case of vortioxetine-induced hypomania in a major depressive disorder patient who previously used various antidepressants but did not experience hypomania or mania. Our case is expected to contribute to the literature.

참고문헌 (27)

  1. Baldessarini RJ, "Antidepressant-associated moodswitching and transition from unipolar major depression to bipolar disorder : a review", J Affect Disord, 148, pp.129~135 (2013)
  2. Barbuti M, "Antidepressant-induced hypomania", mania in patients with major depression : evidence from the BRIDGEII-MIX study, 2017, pp.219, 187~192
  3. Navarro V, "Treatment and outcome of antidepressant treatment-associated hypomania in unipolar major depression : a 3-year follow-up study", J Affect Disord, 155, pp.59~64 (2014)
  4. Valentí M, "Risk factors for antidepressant-related switch to mania", J Clin Psychiatry, 73, pp.e271~e276 (2012)
  5. Gill N, "A review of antidepressant-associated hypomania in those diagnosed with unipolar depression-risk factors, conceptual models, and management", Curr Psychiatry Rep, 22, pp.20~ (2020)
  6. Bennabi D, "Vortioxetine for cognitive enhancement in major depression : from animal models to clinical research", Front Psychiatry, 10, pp.771~ (2019)
  7. Atique-Ur-Rehman H, "Cognitive dysfunction in major depression : from assessment to novel therapies", Pharmacol Ther, 202, pp.53~71 (2019)
  8. Salagre E, "Vortioxetine: a new alternative for the treatment of major depressive disorder", Rev Psiquiatr Salud Ment(Engl Ed), 11, pp.48~59 (2018)
  9. Chun BJ, "A review of antidepressant-induced hypomania in major depression : suggestions for DSM-V", Bipolar Disord, 6, pp.32~42 (2004)
  10. Sanchez C, "Vortioxetine, a novel antidepressant with multimodal activity : review of preclinical and clinical data", Pharmacol Ther, 145, pp.43~57 (2015)
  11. Sowa-Kućma M, "Vortioxetine : a review of the pharmacology and clinical profile of the novel antidepressant", Pharmacol Rep, 69, pp.595~601 (2017)
  12. Maud C, "Vortioxetine in bipolar depression induces a mixed", manic switch, 2016, pp.24, 206~207
  13. Aydın EP, "Hypomanic switch during vortioxetine treatment : a case report", Psychiatry Clin Psychopharmacol, 29, pp.114~116 (2019)
  14. Baldwin DS, "The safety and tolerability of vortioxetine : analysis of data from randomized placebo-controlled trials and open-label extension studies", J Psychopharmacol, 30, pp.242~252 (2016)
  15. D’Andrea G, "Vortioxetine treatment-emergent mania in the elderly : a case report", Australas Psychiatry, 27, pp.413~ (2019)
  16. Sobreira G, "Vortioxetine-induced manic mood switch in patient with previously unknown bipolar disorder", Braz J Psychiatry, 39, pp.86~ (2017)
  17. De Carlo V, "Effectiveness, tolerability, and dropout rates of vortioxetine in comorbid depression : a naturalistic study", Hum Psychopharmacol, 35, pp.e2750~ (2020)
  18. Sani G, "Koukopoulos ׳ diagnostic criteria for mixed depression : a validation study", J Affect Disord, 164, pp.14~18 (2014)
  19. Zimmerman M, "Measures of the DSM-5 mixed-features specifier of major depressive disorder", CNS Spectr, 22, pp.196~202 (2017)
  20. In Hee Shim, "Pharmacological Treatment of Major Depressive Episodes with Mixed Features: A Systematic Review", Clinical Psychopharmacology and Neuroscience, 16(4), pp.376~382 (2018), 대한정신약물학회[DOI]
  21. Koukopoulos A, "DSM-5 criteria for depression with mixed features : a farewell to mixed depression", Acta Psychiatr Scand, 129, pp.4~16 (2014)
  22. "Worsening depression and suicidality in patients being treated with antidepressant medications" (2004)[URL]
  23. Harada T, "Incidence and predictors of activation syndrome induced by antidepressants", Depress Anxiety, 25, pp.1014~1019 (2008)
  24. Hengartner MP, "Protracted withdrawal syndrome after stopping antidepressants : a descriptive quantitative analysis of consumer narratives from a large internet forum", Ther Adv Psychopharmacol, 10, pp.2045125320980573~ (2020)
  25. Kwok C, "Antidepressant-discontinuation mania in two patients with depression", Eur Psychiatry, 30(Suppl 1), pp.1591~ (2015)
  26. Narayan V, "Antidepressant discontinuation manic states : a critical review of the literature and suggested diagnostic criteria", J Psychopharmacol, 25, pp.306~313 (2011)
  27. Shiah IS, "Serotonin in mania and in the mechanism of action of mood stabilizers : a review of clinical studies", Bipolar Disord, 2, pp.77~92 (2000)

관련 논문AI추천

이 간행물의 다른 논문 (20건)